The University of St Andrews

Research Fellow (Marie Curie) – SB1592 (Salary: £45,954 per annum)

We seek to recruit a highly motivated individual for an EU-funded Research Fellowship position to work with Professor Paul Kamer's group.

You will investigate the ‘de novo’ design of transition metalloenzymes, by functionalising proteins with nitrogen ligands and binding them to late transition metals. Adjusting the structures of the biomolecule and the nitrogen ligand will optimise the catalytic performance of these artificial enzymes. This is an EU funded project, as part of the Marie Curie ITN ‘SuBiCat’. We aim to apply techniques from homogeneous catalysis, organic and organometallic chemistry, biological chemistry and molecular biology to optimise the catalytic performance of artificial metalloenzymes in selective oxidation catalysis for lignin degradation.

In addition, the successful candidate will participate in the network’s training activities and work placements at the laboratories of the participating scientific teams and industrial. Regular meetings and workshops within the EU-funded SuBiCat International Training Network (ITN) will supplement the training and support provided at the University of St Andrews.

You will be required to hold a PhD in Molecular biology or biochemistry. The post is fixed term initially for one year, with the possibility of extension for a further year, and will start as soon as possible.

Please be aware of the general Marie-Curie mobility criteria. The applicant cannot have spent more than twelve months in the UK in the last three years prior to the appointment.

Informal enquiries can be directed to: Paul Kamer, Tel. (+44)1334 467285, email

Fixed Term Post for one year in the first instance, with possible extension for a second year.

Closing Date: 9 January 2015 Interview Date: Early February 2015

We encourage applicants to apply online at however if you are unable to do this, please call +44 (0)1334 462571 for an application pack.

Please quote ref: SB1592

The University is committed to equality of opportunity.